医学
醋酸阿比特龙酯
前列腺癌
临床终点
泌尿科
内科学
相伴的
危险系数
随机对照试验
前列腺
强的松
放射治疗
肿瘤科
雄激素剥夺疗法
胃肠病学
癌症
置信区间
作者
Giulio Francolini,Andrea Gaetano Allegra,Beatrice Detti,Vanessa Di Cataldo,Saverio Caini,Alessio Bruni,Gianluca Ingrosso,Rolando Maria D’Angelillo,A.R. Alitto,Matteo Augugliaro,Luca Triggiani,Silvana Parisi,Gaetano Facchini,Marco Banini,Gabriele Simontacchi,Isacco Desideri,Icro Meattini,Richard K. Valicenti,Lorenzo Livi,on behalf of the ARTO Working Group members
摘要
The trial reached its primary end point of biochemical control and PFS, suggesting a clinical advantage for SBRT in addition to first-line AAP treatment in patients with metastatic castration-resistant prostate cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
GingerF
嘻嘻哈哈
GG
fantasy
时尚梦易
Nole
蕃茄鱼
独特广山
不潮薯饼
cdercder
千山keyantong
OK
Samuel
14and15
Raftaar
yjh123
YifanWang
无名氏
youth
皖公网安备34019202002308
